secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628280-25-023442
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo posts updated investor presentation; no material new facts disclosed
--------------------------------------------------------------------------

- Company posted an updated investor presentation on its website on May 8, 2025.
- Presentation is intended for use in investor meetings; no specific financial or pipeline updates provided in the filing.
- No earnings, clinical data, or guidance changes included in the 8-K or exhibit excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828025023442/0001628280-25-023442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828025023442/avtx-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-023442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer